Lili Feng

Person

East Hanover, NJ, US

People

Patents Grantslast 30 patents

Information Patent Grant
Amorphous solid form of compounds containing S—N-valeryl-N- {[2′-(...
- Patent number 11,642,329
- Issue date May 9, 2023
- Novartis Pharmaceuticals Corporation
- Lili Feng
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Glycoside derivatives and uses thereof
- Patent number RE49080
- Issue date May 24, 2022
- Novartis AG
- Gregory Raymond Bebernitz
Information Patent Grant
Amorphous solid form of compounds containing S—N-valeryl-N-{[2′-(1H...
- Patent number 11,096,918
- Issue date Aug 24, 2021
- Novartis Pharmaceuticals Corporation
- Lili Feng
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Solid oral formulations and crystalline forms of an inhibitor of ap...
- Patent number 10,093,665
- Issue date Oct 9, 2018
- Novartis AG
- Jeewan Thakur
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Glycoside derivatives and uses thereof
- Patent number 9,895,389
- Issue date Feb 20, 2018
- Novartis AG
- Gregory Raymond Bebernitz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Solid oral formulations and crystalline forms of an inhibitor of ap...
- Patent number 9,540,363
- Issue date Jan 10, 2017
- Novartis AG
- Jeewan Thakur
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds containing S-N-valeryl-N-{[2′-(1H-tetrazole-5-yl)-bipheny...
- Patent number 9,388,134
- Issue date Jul 12, 2016
- Novartis, AG
- Lili Feng
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Crystalline forms of 5-chloro-N2-(2-isopropoxy-5-methyl-4-piperidin...
- Patent number 9,309,229
- Issue date Apr 12, 2016
- Novartis AG
- Lili Feng
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds containing S-N-valeryl-N-{[2′-(1H-tetrazole-5-yl)-bipheny...
- Patent number 8,877,938
- Issue date Nov 4, 2014
- Novartis Pharmaceuticals Corporation
- Lili Feng
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Glycoside derivatives and uses thereof
- Patent number 8,828,951
- Issue date Sep 9, 2014
- Novartis AG
- Gregory Raymond Bebernitz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Solid oral formulations and crystalline forms of an inhibitor of ap...
- Patent number 8,623,385
- Issue date Jan 7, 2014
- Novartis AG
- Jeewan Thakur
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Glycoside derivatives and uses thereof
- Patent number 8,466,114
- Issue date Jun 18, 2013
- Novartis AG
- Gregory Raymond Bebernitz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Glycoside derivatives and uses thereof
- Patent number 8,163,704
- Issue date Apr 24, 2012
- Novartis AG
- Gregory Raymond Bebernitz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
AMORPHOUS SOLID FORM OF COMPOUNDS CONTAINING S-N-VALERYL-N-{[2'-(1H...
- Publication number 20220331282
- Publication date Oct 20, 2022
- Novartis Pharmaceuticals Corporation
- Lili FENG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
AMORPHOUS SOLID FORM OF COMPOUNDS CONTAINING S-N-VALERYL-N-{[2'-(1H...
- Publication number 20220257551
- Publication date Aug 18, 2022
- Novartis Pharmaceuticals Corporation
- Lili FENG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS CONTAINING S-N-VALERYL-N-{[2'-(1H-TETRAZOLE-5-YL)-BIPHENY...
- Publication number 20210361610
- Publication date Nov 25, 2021
- Novartis Pharmaceuticals Corporation
- Lili FENG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS CONTAINING S-N-VALERYL-N-{[2'-(1H-TETRAZOLE-5-YL)-BIPHENY...
- Publication number 20200016109
- Publication date Jan 16, 2020
- Novartis AG
- Lili Feng
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS CONTAINING S-N-VALERYL-N-{[2'-(1H-TETRAZOLE-5-YL)-BIPHENY...
- Publication number 20200016110
- Publication date Jan 16, 2020
- Novartis AG
- Lili Feng
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS CONTAINING S-N-VALERYL-N-{[2'-(1H-TETRAZOLE-5-YL)-BIPHENY...
- Publication number 20190374498
- Publication date Dec 12, 2019
- Novartis AG
- Lili Feng
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS CONTAINING S-N-VALERYL-N-{[2'-(1H-TETRAZOLE-5-YL)-BIPHENY...
- Publication number 20190374497
- Publication date Dec 12, 2019
- Novartis AG
- Lili Feng
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Solid Oral Formulations and Crystalline Forms of an Inhibitor of Ap...
- Publication number 20180370960
- Publication date Dec 27, 2018
- Novartis AG
- Jeewan Thakur
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS CONTAINING S-N-VALERYL-N-{[2'-(1H-TETRAZOLE-5-YL)-BIPHENY...
- Publication number 20180344679
- Publication date Dec 6, 2018
- Novartis AG
- Lili Feng
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Solid Oral Formulations and Crystalline Forms of an Inhibitor of Ap...
- Publication number 20170081319
- Publication date Mar 23, 2017
- Novartis AG
- Jeewan Thakur
- C07 - ORGANIC CHEMISTRY
Information Patent Application
GLYCOSIDE DERIVATIVES AND USES THEREOF
- Publication number 20170042925
- Publication date Feb 16, 2017
- Novartis AG
- Gregory Raymond BEBERNITZ
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS CONTAINING S-N-VALERYL-N--VALINE AND (2R,4S)-5-BIPHENYL-4...
- Publication number 20160324821
- Publication date Nov 10, 2016
- Lili Feng
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CRYSTALLINE FORMS OF 5-CHLORO-N2-(2-ISOPROPOXY-5-METHYL-4-PIPERIDIN...
- Publication number 20160175305
- Publication date Jun 23, 2016
- Novartis AG
- Lili Feng
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
GLYCOSIDE DERIVATIVES AND USES THEREOF
- Publication number 20150141354
- Publication date May 21, 2015
- Novartis AG
- Gregory Raymond BEBERNITZ
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
GLYCOSIDE DERIVATIVES AND USES THEREOF
- Publication number 20140274921
- Publication date Sep 18, 2014
- Novartis AG
- Gregory Raymond BEBERNITZ
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Solid Oral Formulations and Crystalline Forms of an Inhibitor of Ap...
- Publication number 20140093570
- Publication date Apr 3, 2014
- Novartis AG
- Jeewan Thakur
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CRYSTALLINE FORMS OF 5-CHLORO-N2-(2-ISOPROPOXY-5-METHYL-4-PIPERIDIN...
- Publication number 20130274279
- Publication date Oct 17, 2013
- Novartis AG
- Lili Feng
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
GLYCOSIDE DERIVATIVES AND USES THEREOF
- Publication number 20130017993
- Publication date Jan 17, 2013
- Novartis AG
- Gregory Raymond BEBERNITZ
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
GLYCOSIDE DERIVATIVES AND USES THEREOF
- Publication number 20120178680
- Publication date Jul 12, 2012
- Novartis AG
- Gregory Raymond BEBERNITZ
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SOLID ORAL FORMULATIONS AND CRYSTALLINE FORMS OF AN INHIBITOR OF AP...
- Publication number 20120128742
- Publication date May 24, 2012
- Jeewan Thakur
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Glycoside Derivatives and Uses Thereof
- Publication number 20110171159
- Publication date Jul 14, 2011
- Novartis AG
- Gregory Raymond BEBERNITZ
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Salts and Crystal Modifications Thereof
- Publication number 20090163478
- Publication date Jun 25, 2009
- Lili Feng
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ORGANIC COMPOUNDS
- Publication number 20090156585
- Publication date Jun 18, 2009
- Lili Feng
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SALT
- Publication number 20090131528
- Publication date May 21, 2009
- Lili Feng
- C07 - ORGANIC CHEMISTRY

Person

Patents Grantslast 30 patents

Amorphous solid form of compounds containing S—N-valeryl-N- {[2′-(...

Glycoside derivatives and uses thereof

Amorphous solid form of compounds containing S—N-valeryl-N-{[2′-(1H...

Solid oral formulations and crystalline forms of an inhibitor of ap...

Glycoside derivatives and uses thereof

Solid oral formulations and crystalline forms of an inhibitor of ap...

Compounds containing S-N-valeryl-N-{[2′-(1H-tetrazole-5-yl)-bipheny...

Crystalline forms of 5-chloro-N2-(2-isopropoxy-5-methyl-4-piperidin...

Compounds containing S-N-valeryl-N-{[2′-(1H-tetrazole-5-yl)-bipheny...

Glycoside derivatives and uses thereof

Solid oral formulations and crystalline forms of an inhibitor of ap...

Glycoside derivatives and uses thereof

Glycoside derivatives and uses thereof

Patents Applicationslast 30 patents

AMORPHOUS SOLID FORM OF COMPOUNDS CONTAINING S-N-VALERYL-N-{[2'-(1H...

AMORPHOUS SOLID FORM OF COMPOUNDS CONTAINING S-N-VALERYL-N-{[2'-(1H...

COMPOUNDS CONTAINING S-N-VALERYL-N-{[2'-(1H-TETRAZOLE-5-YL)-BIPHENY...

COMPOUNDS CONTAINING S-N-VALERYL-N-{[2'-(1H-TETRAZOLE-5-YL)-BIPHENY...

COMPOUNDS CONTAINING S-N-VALERYL-N-{[2'-(1H-TETRAZOLE-5-YL)-BIPHENY...

COMPOUNDS CONTAINING S-N-VALERYL-N-{[2'-(1H-TETRAZOLE-5-YL)-BIPHENY...

COMPOUNDS CONTAINING S-N-VALERYL-N-{[2'-(1H-TETRAZOLE-5-YL)-BIPHENY...

Solid Oral Formulations and Crystalline Forms of an Inhibitor of Ap...

COMPOUNDS CONTAINING S-N-VALERYL-N-{[2'-(1H-TETRAZOLE-5-YL)-BIPHENY...

Solid Oral Formulations and Crystalline Forms of an Inhibitor of Ap...

GLYCOSIDE DERIVATIVES AND USES THEREOF

COMPOUNDS CONTAINING S-N-VALERYL-N--VALINE AND (2R,4S)-5-BIPHENYL-4...

CRYSTALLINE FORMS OF 5-CHLORO-N2-(2-ISOPROPOXY-5-METHYL-4-PIPERIDIN...

GLYCOSIDE DERIVATIVES AND USES THEREOF

GLYCOSIDE DERIVATIVES AND USES THEREOF

Solid Oral Formulations and Crystalline Forms of an Inhibitor of Ap...

CRYSTALLINE FORMS OF 5-CHLORO-N2-(2-ISOPROPOXY-5-METHYL-4-PIPERIDIN...

GLYCOSIDE DERIVATIVES AND USES THEREOF

GLYCOSIDE DERIVATIVES AND USES THEREOF

SOLID ORAL FORMULATIONS AND CRYSTALLINE FORMS OF AN INHIBITOR OF AP...

Glycoside Derivatives and Uses Thereof

Salts and Crystal Modifications Thereof

ORGANIC COMPOUNDS

SALT